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Fish oil has protective and therapeutic effects on proteinuria in passive
Heymann nephritis. Passive Heymann nephritis (PHN) is a rat model of
membranous nephropathy induced by injecting anti-Fx1A. The onset of
proteinuria in PHN is caused by complement-mediated injury to gb-
merular epithelial cells (GEC) accompanied by enhanced glomerular
eicosanoid production. In addition, sublethal injury by complement of
rat GECs in culture leads to phospholipase activation, phospholipid
hydrolysis and release of arachidonic acid and dienoic prostanoids.
Based on these findings, we undertook to determine if substituting
arachidonic acid (omega-6) in GEC membrane phospholipids with
omega-3 fatty acids derived from fish oil would alter the development
and course of proteinuria in PHN. We found that rats fed a diet
containing 10% fish oil for four weeks prior to antibody injection
developed 50 to 60% less proteinuria between two and six weeks after
anti-Fx1A than rats fed an equivalent diet containing 10% safflower oil,
and had substantial enrichment of glomerular phospholipids with ome-
ga-3 fatty acids and displacement of arachidonic acid. This outcome
was associated with a 50% reduction in release of glomerular throm-
boxane B2 (stable metabolite of thromboxane A2) in the fish oil group.
More importantly, when PHN rats with well established proteinuria
while on regular chow were randomized to three dietary groups, those
fed fish oil had a 25 to 50% decline in proteinuria as compared to those
fed lard or safflower oil. This difference was evident within two weeks
of randomization and persisted until the end of the study after eight
weeks. In neither study could the differences in urine protein excretion
be accounted for by protein or calorie deprivation, or by differences in
blood pressure, renal function, immune response to sheep IgG, or
glomerular deposition of IgG or complement. Thus, our results indicate
that dietary fish oil has protective and therapeutic effects with regard to
proteinuria in PHN. These benefits may relate to alterations in mem-
brane phospholipid composition in favor of omega-3 fatty acids and
release of less reactive trienoic eicosanoids.
Membranous nephropathy is the most common cause of
idiopathic nephrotic syndrome in adults and an important cause
of chronic renal failure. Even in the absence of renal failure,
many patients with membranous nephropathy suffer consider-
able morbidity from intractable edema. In addition, the hyper-
lipidemia associated with severe nephrotic syndrome and the
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hypertension of advanced renal failure may predispose patients
to accelerated atherosclerosis. To date, no therapy has been
uniformly effective in reducing proteinuria without adversely
affecting renal function. Studies on the pathogenesis of exper-
imental membranous nephropathy suggest a logical therapeutic
strategy that can be tested in a rat model closely resembling
human membranous nephropathy. Passive Heymann nephritis
(PHN) is induced by injection of an antiserum (anti-Fx1A) that
identifies antigens on the glomerular epithelial cell (GEC)
plasma membrane and is characterized by subepithelial immune
deposits. The onset of proteinuria is mediated by the C5b-9
membrane attack complex of complement which assembles in
the GEC plasma membrane and produces alterations in GEC
morphology and enhanced glomerular eicosanoid production
[reviewed in 1]. In addition, antibody-directed insertion of
C5b-9 into rat GECs in culture leads to phospholipase C and A2
activation, membrane phospholipid hydrolysis and prostanoid
release [2]. These findings suggest that GEC membrane phos-
pholipid hydrolysis might contribute to the development of
proteinuria, perhaps through the intermediary action of throm-
boxane A2 (TXA2) or other lipid mediators [4—61.
Many human and animal studies have shown that dietary
supplementation with fish oil, a major source of omega-3 fatty
acids, alters membrane phospholipid fatty acid composition and
eicosanoid production [6—8]. Eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), the most abundant omega-3 fatty
acids, accumulate in the plasma membrane and partially replace
arachidonic acid (AA) as substrates for cyclooxygenase and
lipoxygenase. The cyclooxygenase and lipoxygenase products
of EPA (especially TXA3 and LTB5) have much less vasocon-
strictive and inflammatory action than those of AA (TXA2 and
LTB4) [9, 10]. These alterations may well be responsible for the
beneficial effects of fish oil in murine lupus nephritis [11] and
other models of experimental nephritis [12]. Fish oil also
favorably alters various factors that may contribute to progres-
sive glomerular injury and atherosclerosis, including blood
rheology [13], platelet aggregation [8] and plasma lipid compo-
sition [14, 15].
We undertook this study to determine if fish oil affects the
development and course of proteinuria in PHN and, if so, to
define possible mechanisms by analyzing the influence of fish oil
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on the primary immune response, antibody deposition, comple-
ment-induced glomerular prostanoid production and renal func-
tion during and after active immune injury. In addition to
demonstrating substantial protection against the development
of proteinuria in PHN, our results are the first to document a
therapeutic effect of dietary fish oil in rats with established
membranous nephropathy. Possible mechanisms for this out-
come are discussed.
Methods
Animals and materials
Female Sprague-Dawley rats were obtained from Charles
River Laboratories (Wilmington, Massachusetts, USA). 3H-
POE2, 3H-TXB,, 1251 and 3H-inulin were purchased from
Du Pont-New England Nuclear Research Products (Boston,
Massachusetts, USA). PGE2, TXB, and albumin standards
were purchased from Sigma Chemicals (St. Louis, Missouri,
USA), and antisera to PGE7 and TXB, were obtained from
Advanced Magnetics (Cambridge, Massachusetts, USA). Para-
aminohippuric acid (PAR) was obtained from Aldrich Chemical
Co. (Milwaukee, Wisconsin, USA).
Diets
Experimental and control diets consisted of an isocaloric rat
chow (Ralston Purina, Richmond, Indiana, USA) containing
21% protein (casein), 59% carbohydrate (sucrose and dextrin),
10% lipid and supplements (mineral and vitamin mix). The lipid
in the experimental diet was derived from fish oil (MaxEPA oil,
provided by R.P. Scherer, Troy, Michigan, USA), a source of
omega-3 fatty acids. Vitamin E, 50 lU/kg, was added to the diet
and the fish oil and diets were stored at —20°C to prevent
peroxidation. The lipid content of the control diets was made up
of safflower oil, a source of omega-6 fatty acids, or lard, a
source of saturated fat. The diets were prepared before each
experiment and rats were pair-fed as follows. Based on their
average daily food consumption prior to dietary modification,
rats were given sufficient food to last about two days. Since the
safflower and lard fed rats ate their food more quickly than the
fish oil group, the food hoppers were not refilled until the fish oil
group had finished their ration. All rats were weighed every two
weeks to ensure equal food intake and weight gain.
Experimental protocols
Two experimental protocols were established to study the
effect of dietary lipids on the development of proteinuria
(Preventive study) and on already established proteinuria
(Therapeutic study). In the preventive study, PHN was induced
by injection of anti-Fx1A after both groups of rats had been fed
their respective diets (fish oil or safflower oil) for four weeks.
The animals continued on their diets and were followed for six
to eight weeks after anti-FxlA injection, that is, well into the
autologous phase of proteinuria. In the therapeutic study, all
animals were injected with anti-Fx1A and maintained on regular
rat chow (Rodent Laboratory Chow 5001, Ralston Purina) until
the autologous phase of proteinuria was established (3 weeks).
At this point, the animals were randomly assigned to receive
diets containing either fish oil, safflower oil or lard and were
followed for eight weeks. In both studies, urine and blood were
collected biweekly to assess proteinuria, renal function, host
immune response and plasma lipids. In addition, a subgroup of
rats fed either fish oil or safflower oil for four weeks was
sacrificed to measure the glomerular phospholipid fatty acid
composition prior to antibody injection.
Experimental procedures
Induction of passive Heymann nephritis. PHN was induced
in anesthetized (3% chloral hydrate, 1 ml/100 g body wt i.p.)
rats (200 to 250 g) by two intravenous injections of 1.0 and 075
ml of sheep anti-Fx1A 24 hours apart. Preparation and charac-
terization of this antiserum has been described [16]. Rats fed the
fish oil diet had a higher mortality rate from anesthesia and
antibody injection than the other animals (15% vs. 10%). Urine
protein excretion was measured biweekly by the sulfosalicylic
acid method using a commercial serum standard [16]. At the
end of both studies all animals were sacrificed and kidneys were
removed for morphologic studies. Renal clearance studies were
performed on selected rats on day 10. Other animals were
sacrificed on day 6 and kidneys were removed for isolation of
glomeruli to measure glomerular prostanoid production and
antibody deposition.
Glomerular antibody deposition. A dual isotope method was
used to assess the potential effect of various dietary lipids on
glomerular antibody deposition [16]. Rats were injected with 15
mg '251-labeled Yi anti-Fx1A (2 x 106 cpm/rat), prepared and
characterized as previously described [16], On day 6 after
anti-FxlA, all animals were injected with 131j BSA to account
for nonspecific glomerular binding and were sacrificed one hour
later. Glomeruli were isolated from the kidneys of individual
rats by differential sieving and were enumerated in a Fuchs-
Rosenthal hemocytometer. 125J and 1311 radioactivity of glomer-
uli and serum were measured in a gamma counter and specific
glomerular deposition of 125j labeled anti-Fx1A was calculated
as described [11. Results are expressed as micrograms of IgG
bound/38,000 glomeruli.
Fatty acid composition of glomerular phospholipids. Glomer-
uli were isolated, washed with ice-cold phosphate-buffered
saline, pH 7.4 (PBS), and stored at —70°C until assayed. Tissue
lipids were extracted using a procedure modified from that of
Foich et al [171. A 2:1 mixture of chloroform/methanol (C/M)
was used to extract total lipids from isolated glomeruli. The
organic layer was evaporated under N2, resolubilized in C/M
(2:1) and separated by thin layer chromatography using LK6D
silica gel plates (Whatman Inc., Clifton, New Jersey, USA) and
a solvent system of hexane:ethylether:glacial acetic acid (70:
30:1). The phospholipid region was identified from co-chro-
matographed standards, scraped, and the lipids eluted from the
gel with C/M (1:1) and concentrated. Transmethylation was
performed using BF3/CH3OH (Supelco, Bellafonte, Pennsylva-
nia, USA) [18]. Fatty acid methylesters were separated on a 6
foot glass gas-chromatography column (Hewlett Packard Co.,
Avondale, Pennsylvania, USA) packed with GP 5% DEGS-PS
on 100/200 Supelcoport (Supelco) and equipped with a flame
ionization detector. The carrier gas N2 flow rate was 40 mllmin.
The oven, injector and detector temperatures were 170, 250 and
250°C, respectively. Peaks were identified according to authen-
tic standards (Supelco) and quantification was performed using
an auxiliary integrator.
Measurement of glomerular prostanoid production. All kid-
neys were perfused with 200 ml of ice-cold PBS in vivo prior to
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removal. Glomeruli were then isolated by sieving and incubated
in plastic tubes containing 2 ml of Krebs-Ringer-bicarbonate
buffer, pH 7.2, for 30 minutes at 37°C according to the method
of Stahl et a! [4]. Glomerular PGE2 and TXB2 production were
determined by direct radioimmunoassay of the indomethacin-
treated supernatants without prior extraction or chromato-
graphic separation. The specific assay procedures have been
described in detail elsewhere [5]. The cross reactivity of other
arachidonate metabolites with the utilized antisera at 50%
displacement were as follows: anti-PGE2: PGE1 50%, PGA2
6%, PGA1 3%, PGF2 1.3%, 6-keto-PGE1 1%, l5-keto-PGF2
1%, 15-keto-PGE2 1%, all other AA metabolites <1%; anti-
TXB2: all measured AA metabolites <0.1%. All results are
expressed as picogram of prostanoid per milligram of glomeru-
tar protein per minute incubation time.
Measurement of host immune response. Rat anti-sheep IgG
serum titers were measured by ELISA to determine the host
immune response to injected sheep anti-Fx1A. Microtiter plates
(Falcon, Becton Dickinson Co., Oxnard, California, USA) were
coated with normal sheep IgG (10 pg/ml in PBS) and incubated
for 16 hours at 4°C in an air-tight moist chamber. The antigen
was discarded and blocking buffer (1% BSA-0.15 M Tris-HC1,
pH 7.6) was added and incubated for one hour at room
temperature. All wells were washed three times with washing
buffer (0.05% Tween 20, 15 mi Tris-HC1, pH 7.6, 135 mM
NaCl). Serially diluted (1/50-1/800) test sera were added and
incubated for one hour at room temperature. The serum sam-
ples were then removed and wells washed again with washing
buffer. Biotinylated goat anti-rat IgG (Cappel Laboratories,
Cochranville, Pennsylvania, USA) at a 1/1000 dilution was
added and incubated for one hour at room temperature. After
washing, wells were incubated with avidin-peroxidase (Cappel,
2.5 pg/ml) for 30 minutes at room temperature. After a final
wash, freshly prepared developing buffer containing 50 mM
phosphate-citrate (pH 5), 0.04% (wt/vol) ortho-phenylenedia-
mine and 0.014% (vol/vol) H202 was added to the welts and
incubated for 5 to 10 minutes. The reaction was stopped with
2.5 M H2S04 to each well and absorbance was read at 490 nm in
a Minireader II (Dynatech Laboratories, Inc., Alexandria,
Virginia, USA). Nonspecific reactivity was determined from
control reactions in which serum samples were deleted. All
measurements were performed in duplicate and results are
expressed in arbitrary ELISA units as described in detail by
Butler, Cantarero and McGivern [19].
Measurement of serum albumin. Serum albumin was mea-
sured by ELISA in which plates were coated with sheep anti-rat
albumin (Cappel Laboratories) dissolved in PBS at a concen-
tration of 20 g/ml. Mter coating and appropriate blocking and
washing steps, albumin standards and test sera, at a dilution of
1 x 10, were added, and subsequently assayed and developed
with biotinylated sheep anti-rat albumin followed by avidin-
peroxidase. All measurements were performed in duplicate and
test results were read off a standard curve relating albumin
concentration to OD 490 nm.
Measurement of serum creatinine, triglyceride and choles-
terol. All measurements were performed by the University
Hospital clinical laboratory using standard automated methods.
Clearance studies. Rats were anesthetized with 3% chloral
hydrate (1 ml/l00 g body wt), After tracheostomy, polyethylene
catheters (PE 50, Clay Adams, Parsippany, New Jersey, USA)
were placed in the right jugular vein and femoral artery to infuse
plasma, 3H-inulin and PAH and to monitor mean arterial
pressure and to collect blood. Mean arterial pressure was
measured by an electronic transducer (model 1280 C, Hewlett
Packard) connected to a recorder (model 7282 A, Hewlett
Packard). To maintain euvolemia during the experiment, each
rat received a continuous intravenous infusion of isooncotic rat
plasma (1 ml/100 g body wt) for the first 30 minutes. Glomerular
filtration rate and whole kidney effective renal plasma flow rate
were measured by inulin and PAH clearance, respectively.
3H-inulin and 0.9% PAH in 0.9% NaCl were infused at a
constant rate of 0.028 mllmin. After a 40-minute equilibration
period, three collection periods of 20 minutes each were per-
formed. 3H-inulin in blood and urine samples was measured in
a lipid scintillation counter. PAH was determined in protein-
free filtrates of plasma and urine by a colorimetric method [20].
The clearances were calculated from standard equations.
Morphologic studies. At the end of both studies kidney tissue
from representative rats was examined by light microscopy
(LM), immunofluorescence (IF) and electron microscopy (EM).
Tissue for LM was fixed in 10% neutral buffered formalin,
sectioned at 4 microns, and stained with hematoxylin and eosin
stain. Tissue for IF was snap frozen in dry-ice-isopentane, and
sectioned and stained as previously described [16, 21]. Antisera
utilized in the staining procedure included fluorescein-conju-
gated IgG fractions of monospecific polyclonal antibodies
against sheep IgG, rat IgG and rat C3 (Cappel Laboratories) and
monoclonal anti-rat CSb-9 (from WG Couser, University of
Washington). Cortical kidney tissue was fixed in situ with
Karnovsky's fixative and processed further for EM as de-
scribed before [22].
Statistical analysis
The values given in tables and text are expressed as mean
SD unless indicated otherwise. All analyses were done with
StatViewTM 512 + (BrainPower, Inc., Calabasas, California,
USA). Two-way analysis of variance (ANOVA) was used to
test changes within groups and between groups over time. A
two-tailed unpaired t-test was used for comparisons between
two groups, and a paired (-test was used where indicated for
before and after comparisons within groups. Mann-Whitney U
test and Kruskal-Wallis analysis of variance were used for
nonparametric data. A P value of <0.05 was considered signif-
icant,
Results
Effect of dietary fatty acid substitution on fatty acid content
of glomerular phospholipids and on growth rate
Since glomerular epithelial cells are the primary targets of
injury in this model, we analyzed glomerular phospholipid fatty
acid composition to determine the degree of omega-3 fatty acid
substitution of plasma membranes. The results are shown in
Table 1. Total glomerular omega-3 fatty acid content in the fish
oil group was 10-fold and 20-fold greater than that in the lard
and safflower oil groups, respectively. Arachidonate (w-6 20:4)
content in the fish oil group was reduced by about 50%
compared to the control diets indicating a substantial reduction
of substrate for the cyclooxygenase and lipoxygenase enzyme
systems. The safflower oil group had the highest omega-6 fatty
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Fatty
acid Lard
Safflower
oil
Fish
oil
14:0 1.2 0.8 0.0
16:0 15.9 16.9 16.4
w-9 16:1
17:0
18:0
1.3
5.7
24.9
0.0
5.4
24.3
2.2
7.2
25.3
o-9 18:1 9.0 8.7 10.5
o-6 18:2 7.5 12.8 6.2
w-3 18:3 0.0 0,2 0.0
o-6 20:4 25.1 22.0 11.3
o.3 20:5 0.8 0.3 9.2
(0-9 24:1 4.4 3.7 0.0
a'6 22:4 3.0 4.2 2.5
(0-3 22:5 0.0 0.0 4.8
(0-3 22:6 1.0 0.4 4.5
total o,.3 1.8 0.9 18.5
total o-6 35.6 39.0 20.0
Values are expressed in mol % of total glomerular phospholipid fatty
acid content and represent the mean of three animals in each dietary
group.
acid content reflecting the high omega-6 fatty acid content of
this diet (76.9%).
In a cohort of rats following the preventive protocol, animals
were weighed eight times during the four-week pre-immuniza-
tion period of feeding with fish oil (FO) or safflower oil (SO).
Growth rates, as determined by body weight gain, were similar
in the two groups and the weights after four weeks were not
significantly different (FO: 210.4 15.6 g, N 16; SO: 229.2
12.4g;N= 11;P=rNS).
Effect of dietary fatty acid substitution on proteinuria, body
weight and serum albumin
Preventive study. Animals were fed their respective diets for
four weeks and then were injected with anti-Fx1A. Urine
protein excretion was significantly reduced in the fish oil group
at 14 days after antibody injection (FO: 74.5 12.5; SO: 226.5
25.6 mg124 hr) and this difference persisted until the end of
the study at 42 days (FO: 49.6 10.7; SO: 91.6 14.4 mg124 hr;
Fig. 1). Five days after antibody injection only about half the
animals in each group was proteinuric and, therefore, statistical
analysis was not performed at this time point. Rats in the
safflower group gained slightly but significantly more weight
after disease induction than the fish oil group (after 6 weeks FO:
21.1 7.7%, N 7; SO: 30.1 11.1%, N = 9; P < 0.05).
Serum albumin concentrations declined markedly 14 days after
antibody injection as compared to predisease levels and re-
turned towards normal levels after seven weeks (Fig. 3). The
difference between the levels of the fish oil and safflower oil
groups at 14 days was not statistically significant although it was
in accord with the milder proteinuria in the fish oil group.
Therapeutic study. All animals in this study were injected
with anti-Fx1A and maintained on regular rat chow until the
autologous phase was established and rats were severely pro-
teinuric (3 weeks). At this point the animals were randomized to
three different diets. Lard, a diet that closely resembles regular
rat chow in terms of total lipid fatty acid composition, was
Time after anti-Fx1A, days
Fig. 1. Effect of dietary lipids on the development of proteinuria in
passive Heymann nephritis (preventive study). Rats were fed safflower
oil (, 10) or fish oil (U, 7) for four weeks and were then injected with
anti-FxIA on day 0 and day I. Values are mean SE. Numbers in
parentheses represent the number of animals in each group. * ANOVA
P < 0.01 (FO vs. SO).
Time after initiation of diets, days
Fig. 2. Effect of dietary lipids on established proteinuria in passive
Heymann nephritis (therapeutic study). Three weeks after anti-FxlA
when proteinuria was well established (day 0), rats were randomized to
three dietary groups [lard, (8), safflower oil, PA (15), or fish oil, U
(15)1 and the effect on urine protein excretion was measured every two
weeks. Numbers in parentheses represent the number of animals in
each group. Values are mean SE. * ANOVA P < 0.05 (FO vs. SO +
lard).
added as a second control diet in this study to determine if the
apparent benefit observed in initial experiments with fish oil
might instead have been due to an adverse effect of safflower
oil. Fourteen days after randomization urine protein excretion
was significantly reduced in the fish oil group compared to the
two control groups (Fig. 2). This difference remained significant
until the end of the study period (Fig. 2) despite wide variations
in urinary protein excretion in both control groups during this
time. There was no difference in urinary protein excretion
between the lard and the safflower oil groups at any time during
the study period, which allows us to draw two conclusions.
Table 1. Glomerular phospholipid fatty acid content of glomeruli from
rats fed lard, safflower oil or fish oil for four weeks
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Dietary groups
Fig. 3. Serum albumin before (pre, U) and after immunization (PA 2
weeks; D 4 weeks; 7 weeks) in rats fed fish oil (FO) or safflower oil
(SO) from four weeks prior to anti-FxIA injection. Values are mean
s. * P < 0.001 (paired 1-test before and after immunization), # P < NS
(FO vs. SO).
Table 2. Effect of dietary lipids on glomerular antibody binding six
days after administration of anti-FxIA
Dietary lipid
Glomerular antibody
binding, ugIkidney(mean SD)
SO (9) 22.8 4.5
FO (9) 23.9 6.0
Number of animals is in parentheses. P = NS (unpaired 1-test).
First, there is no independent effect of the degree of fatty acid
saturation on proteinuria in this model. Second, the difference
in protein excretion between fish oil and safflower oil is due to
a beneficial effect of the marine oil rather than a harmful effect
of safflower oil.
Two weeks after randomization of heavily proteinuric rats to
the various diets, weight gain was less in the fish oil group (FO:
9.9 6.1%, N = 15; SO: 16.1 7.6%, N = 15; lard: 16.5 4.8,
N 8; P < 0.02) but by four weeks weights in the three groups
had equalized. We did not attempt to determine body water
content to account for potential differences in fluid retention.
Serum albumin levels were mildly reduced in all groups at the
time of randomization to the different diets and remained
similarly low throughout the study (after 8 weeks FO: 40.0
5.8 g/dl, N = 15; SO: 38.9 4.9 g/dl, N = 14; lard: 36.2 4.8
gIdl, N = 7; P = NS).
Effect of dietary fatty acid composition on glomerular
antibody deposition and host immune response to anti-FxIA
Potentially, the observed benefits of fish oil on proteinuria
could be due to decreased glomerular deposition of antibody or
a blunted humoral response by the host to injected sheep
anti-Fx1A. This is not supported by the results shown in Tables
2 and 3. Glomerular antibody deposition was not significantly
Table 3. Effect of dietary lipids on the host antibody response to
anti-Fx1A as measured by the serum titer of rat anti-sheep IgG
Preventive
Weeks after anti-FxlA
2 4 8
S0(9) 5.35 4.70 1.90
0.30--8.05 0.95—15.85 0.35—13.60
FO (5) 4.75 10.00 4.00
3.95—33.35 2.55—20.85 0.65—9.30
Therapeutic
Weeks after anti-FxIA
3 7
Lard (7) 3.00 5.30
0.40—9.80 0.30—20.90
SO (7) 9.60 3.00
2.05—23.40 0.00—8.95
FO (8) 3.85 6.30
1.20—23.45 0.40—22,85
Values are median ELISA units and range. Number of samples tested
is in parentheses. Nonparametric statistical analyses showed no signif-
icant differences between groups at any time point.
different between the fish oil and safflower oil groups six days
after injection of 15 mg '251-anti-Fx1A (Table 2), and was within
a range similar to that previously reported [23].
The effect of the various diets on the humoral immune
response to injected sheep anti-Fx1A was measured two, four
and six weeks after antibody injection in the preventive study
and after three and seven weeks in the therapeutic study. There
was no significant difference between the groups at any time
(Table 3) to explain the decline in proteinuria seen in the fish oil
group.
Glomerular prostaglandin synthesis
The results of TxB2 and PGE2 synthesis by isolated glomeruli
from PHN and control rats (injected with normal sheep IgG) in
the heterologous phase (6 days after antibody injection) are
shown in Figures 4 and 5. In rats fed safflower oil, TXB2
synthesis by nephritic glomeruli was significantly elevated
compared to that of normal controls. Fish oil lowered basal
glomerular TXB2 production in controls and prevented the
increase in PHN (Fig. 4). There was no difference in PGE2
synthesis between nephritic and control glomeruli on either
diet, although PGE2 synthesis was significantly reduced in
glomeruli from fish oil fed rats when compared with those fed
safflower oil (Fig. 5), reflecting the reduced diene-prostaglandin
synthesis in animals fed a diet rich in fish oil.
Effect of dietary lipids on renal function
To examine the possibility that the reduction in proteinuria
with fish oil in the preventive study may reflect alterations in
renal function, we measured renal hemodynamics in animals 10
to 14 days after anti-FxlA. The safflower oil and the fish oil
groups with PHN exhibited a decline in inulin clearance of
about 25% and 6% and effective renal plasma flow rate of about
47% and 21%, respectively, when compared to normal non-
nephrotic animals [241. As shown in Table 4, the fish oil group
of PHN rats had significantly higher effective renal plasma flow
rate, and a trend towards higher inulin clearance and decreased
filtration fraction than the safflower oil group. Mean arterial
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Table 5. Effect of dietary lipids on renal function as measured by
serum creatinine in rats injected with anti-Fx1A
Group Serum creatinine mg/dl (mean SD)
Preventive
SO (8)
FO (5)
Before anti-FxIA 3 weeks after anti-FxIA
0.40 0.07 0.54 o.05
0.39 0.15 0.56 020
Therapeutic
Lard (7)
SO (7)
FO (8)
8 weeks after randomization to diet
0.74 0.15c
0.60 0.12"
0.56 0.14
a p < 0.05 vs. before anti-Fx1A
bp NS vs. SO; ANOVA
P < 0.05 vs. SO and FO
"P = NS vs. FO; ANOVA
Fig. 4. Glomerular thromboxane B2 production in the heterologous
phase (preventive study). Symbols are: (fl) PHN group (7); () control
group (3). Numbers in parenthesis represent number of animals. Values
are mean SE. * P < 0.05 (FO PHN vs. SO PHN) ** P < 0.05 (SO
PHN vs. SO control).
Fig. 5. Glomerular prostaglandin E2 production in the early heterolo-
gous phase (preventive study). Symbols are: (EJ) PHN group (7); ()
control group (3). Numbers in parenthesis represent number of animals.
Values are mean SE. * P < 0.05 (FO vs. SO; both PHN and control).
Table 4. Effect of dietary lipids on renal hemodynamics
Inulin
clearance Effective RPF Filtration
MAP mm Hgfraction %mi/mm
SO (4) 0.724 0.115 1.896 0.411 39,93 4.59 98.4 6.0
FO (4) 0.911 0.l39a 2.833 0.406" 32.55 354a 101.8 35a
Values are mean SE. Numbers of animals are in parentheses.
Abbreviation is MAP, mean arterial pressure.
a Not significant
, P < 0.05 (FO vs. SO)
pressure was similar in the two groups. Renal function was also
evaluated from serial measurements of serum creatinine and
representative results are shown in Table 5. In the preventive
study, the serum creatinine was elevated by about 35% in both
the fish oil and safflower oil groups reflecting the reduced inulin
clearance observed earlier. Similar increases in serum creati-
Table 6. Effect of dietary lipids on plasma cholesterol and
triglyceride in rats injected with anti-Fx1A
Cholesterol
Group mg/dl
Triglyceride
Preventive, 3 weeks after anti-FxIA
SO (9) 134.4 40.4
FO (5) 96.4 l5.3a
99.9 58.6
64.0 113b
Therapeutic, 8 weeks after randomization to diet
Lard (7) 192.6 106.5
SO (7) 180.1 94.0c
FO (8) 114.1 55,7J
219.9 146.0
151.6 46.6c
50.5 17.4e
Number studied is in parentheses. Data are means SD.
a p < 0.1; b P < 0.5; Student's 1-test
P = NS vs. lard;" P NS vs. lard and SO; Cp < 0.05 vs. lard and
SO; ANOVA
nine were seen in the fish oil and safflower oil groups in the
therapeutic study, but the level was significantly higher in the
group on a lard diet (Table 5).
Effect of dietary lipids on plasma lipids and blood pressure
The effect of dietary lipids on the plasma lipid profile is shown
in Table 6. Plasma cholesterol and triglycerides were consis-
tently lower in the fish oil group in both studies, but only the
triglyceride level in the therapeutic study reached statistical
significance. In the preventive study, mean arterial pressure of
anesthetized rats in the early autologous phase was not different
in the safflower and fish oil groups (Table 4). Similarly, systolic
blood pressure was not significantly different in awake rats at
any time point after randomization in the therapeutic study
(after 8 weeks FO: 134 14.9, N = 8; SO: 140 14.7, N 7;
lard: 143 14.2 mm Hg, N = 7; P = NS).
Morphologic studies
Immunofluorescence at the end of both the preventive and
therapeutic studies showed moderate granular staining of cap-
illary loops for rat IgG and sheep IgG and trace staining for rat
C3. There were no apparent differences between the fish oil
group and the two control groups. Staining for CSb-9 was
present and of similar intensity and distribution in all animals
from both studies (Fig. 6). Similar light microscopic changes
were seen in the glomeruli of all nephritic groups in both
studies. The glomeruli were uniformly enlarged, the capillary
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Fig. 6. Representative glomeruli stained for C5b-9 from PHN rats
maintained on fish oil (a) and safflower oil (b)for four weeks before and
seven days after anti-FxIA injection (x 400).
loops were dilated and there was no hypercellularity. A mod-
erate interstitial infiltrate was present in all nephritic groups and
was not affected by dietary lipid content.
To determine if there was an ultrastructural basis for the
differences in proteinuria, four glomeruli from three separate
rats from each group were examined by electron microscopy in
the preventive study. All animals displayed the same changes in
glomerular capillary wall architecture. The most prominent
abnormal features were the presence of numerous subepithelial
electron dense deposits and extensive foot process effacement
(Fig. 7 A and B). These changes were found in each glomerulus
and appeared to occur with the same general frequency and
severity in both groups of animals (FO and SO). In addition,
blebbing of the surface membrane and intracellular absorption
droplets were seen in the podocytes in both groups. In all cases,
the endothelial cells appeared normal and there were no inflam-
matory cell infiltrates or evidence of fibrin deposition within any
of the glomeruli examined.
Discussion
The principal findings of our study are that the development
of proteinuria is substantially inhibited and established protein-
uria is remarkably lowered when rats with PHN are fed a diet
enriched with fish oil. To the best of our knowledge, this is the
first report of a therapeutic effect of fish oil in experimental
glomerulonephritis. The effects of fish oil are likely due to the
incorporation of omega-3 fatty acids into the membrane phos-
pholipid fraction of glomerular cells as shown by a 10- to 20-fold
increase in the total glomerular omega-3 fatty acid content
compared to control diets and a reduction in glomerular AA
content of about 50%. These and similar findings by others
[25—27] indicate that four weeks of dietary fish oil is sufficient to
induce near maximal glomerular membrane phospholipid fatty
acid substitution.
Dietary omega-3 fatty acid supplementation provided marked
but incomplete protection against the development of protein-
uria. The beneficial effect was first evident during the heterol-
ogous phase and persisted for at least six weeks, that is, well
into the autologous phase. The effects of fish oil feeding during
the most proteinuric phase (2 weeks after antibody) appeared
also to be reflected in a less severe fall in serum albumin and in
a more modest weight gain. The protection could not be
explained by group differences in glomerular antibody binding,
blood pressure or renal function, or by protein or calorie
deprivation. Moreover, dietary omega-3 fatty acid supplemen-
tation did not inhibit the autologous immune response to sheep
IgG or limit the amount of immunoreactive C3 or C5b-9
deposited in glomeruli. However, because immunofluorescence
is not a quantitative technique, we cannot exclude the possibil-
ity that omega-3 substitution of target cells reduces the assem-
bly of C5b-9 in the plasma membrane or accelerates its removal.
These findings contrast with those of Scharschmidt et al [28],
who found that the benefits of fish oil on proteinuria and GFR in
an accelerated autologous phase model of rat nephrotoxic
nephntis were accompanied by reduced humoral immunity to,
and slower immune elimination of, the injected antiserum. On
the other hand our studies agree closely with those by Rahman,
Sauter and Young [29], who showed that pretreatment with fish
oil reduced the development of proteinuria, inhibited glomeru-
lar eicosanoid production, and preserved renal function without
qualitatively altering glomerular immune deposits or host im-
mune response in a planted antigen model of membranous
nephropathy. Together these two studies of membranous ne-
phropathy show that despite an equivalent degree of sublethal
glomerular epithelial cell injury, fish oil therapy ameliorates
proteinuria, the major functional manifestation of this lesion.
Our results differ from those of Stahl et al [4] and Rahman et al
[29] in one respect: we found no increase in glomerular POE2 in
PHN rats on the omega-6 diet. While there is no obvious
explanation for this difference, it may have to do with differ-
ences in the type and content of lipids in the control diets.
The most original and important result was obtained in the
therapeutic study. When rats with severe, well-established
proteinuria were randomized to receive saturated fat (lard) or
two unsaturated fat diets (omega-3 or omega-6), urine protein
excretion in those fed omega-3 fell by about 50% within two
weeks and remained significantly lower than in those fed lard or
safflower oil for the duration of the study. Again the differences
in urine protein excretion could not be accounted for by protein
or calorie deprivation, or by differences in blood pressure, renal
function, immune response to sheep IgG or glomerular IgO or
complement deposition. As in other studies of PHN in rats fed
standard rat chow [24, 30], we found that GFR was reduced by
about 30 to 40% during the autologous phase in rats on fish oil
or safflower. Interestingly, rats fed lard in our study experi-
enced an even larger increase in serum creatinine than those fed
safflower or fish oil. The explanation of this finding is presently
unknown.
The role of lipid mediators in the pathogenesis of proteinuria
in this model is incompletely understood. Antibody-induced
C5b-9 assembly stimulates glomerular eicosanoid synthesis,
especially TxA2 [4, 5], but pharmacologic inhibition of cycloox-
ygenase and thromboxane synthetase in PHN has had variable
effects on proteinuria. In an isolated perfused rat kidney model
of PHN in which proteinuria was shown to be due to C5b-9-
induced GEC injury [31], Cybulsky et al showed that high-grade
inhibition of thromboxane synthetase with OKY-046 reduced
proteinuria by about 60% [5]. On the other hand, Stahl and
colleagues reported that 80 to 90% inhibition of C-induced
glomerular TxA2 production with UK-38485 in vivo was not
accompanied by a decrease in proteinuria [4]. Not surprisingly,
Zoja, et a! also found that lesser degrees of thromboxane
synthetase inhibition (40%) were without effect on proteinuria,
but they showed a substantial reduction in proteinuria after
cyclooxygenase inhibition with indomethacin [32]. Since ultra-
structural studies in our current study showed equivalent GEC
injury in all dietary groups, it appears that the effect of
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Fig. 7. Representative electron micrographs of glomerular capillary walls from PHN rats maintained on fish oil (a) and safflower oil (b) for four
weeks before and seven days after anti-FxIA injection. Prominent subepithelial electron-dense deposits (arrows) are present in both groups of
animals. Broad foot processes (*), containing dense accumulation of cytoskeletal elements, are also seen in the epithelial podocytes (Ep). The
endothelial layer (En) is normal and no inflammatory cells are present in the capillary lumens (CL). Abbreviations are: RBC, erythrocyte; US,
urinary space. a and b x 21,000. Scale bar = 1 m.
thromboxane (or other diene-lipid mediators) on glomerular
permselectivity in PHN may be to exaggerate the sieving defect
[241 caused by antibody and complement [5, 30].
The present study supports this view. Fish oil completely
inhibited the increase in glomerular TxA2 production seen after
six days in PHN rats on safflower oil and substantially attenu-
ated proteinuria. To understand why fish oil is more effective
than thromboxane synthetase inhibitors in vivo it is important to
appreciate that EPA and DHA have at least two effects with
regard to thromboxane. First, they divert thromboxane down
the less inflammatory triene pathway leading to TxA3 instead of
TxA2. Second, TxA is an effective competitive inhibitor of any
TxA2 that is generated [33]. Thus, fish oil blocks both the
generation and action of TxA2.
Since omega-3 fatty acid substitution has multiple effects, it is
appropriate to consider other mechanisms that might account
for the beneficial action of fish oil in PHN. Marine oils also alter
the production of peptide (including interleukin 1 and tumor
necrosis factor) and other lipid mediators (LTB4) of inflamma-
tion [10, 29, 34]. As yet there is no evidence that peptide
mediators have any role in human or experimental membranous
nephropathy. Although Lianos et al noted that LTB4-producing
leukocytes populate the glomeruli of PHN rats during the first
few hours after antibody injection, neither he nor Rahman et al
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found evidence that LTB4 contributes to proteinuria in experi-
mental membranous nephropathy [29, 35, 36]. On the other
hand, it was recently reported that LTD4, presumably derived
from infiltrating monocytes, contributes to proteinuria and
alters glomerular hemodynamics in the early autologous phase
of PHN [37]. These findings correspond to a report by Hara et
al who found that monocytes contribute to proteinuria at a
similar stage in PHN [38]. Thus, although we have never found
evidence of leukocyte involvement in early PHN [1, 2, 21], it is
possible that fish oil might act in the autologous phase by
inhibiting the production of 4-series leukotrienes by monocytes.
It is also worth relating our observations to those of other
investigators who have used a diet deficient in essential fatty
acids (EFAD) to study the role of inflammatory cells in various
forms of renal injury [39, 40]. Although both omega-3 substitu-
tion and EFAD deplete cellular phospholipids of omega-6 fatty
acids and reduce TxA2 and LTB4 production, the benefits of
EFAD, at least in nephrotoxic nephritis, appear to be due to
decreased production of a novel lipid chemoattractant and
depletion of resident or infiltrating macrophages and not to an
effect of eicosanoids [41].
Proteinuria in PHN results from GEC injury caused by
formation of the C5b-9 complex. Effacement of foot processes,
villous transformation and vesiculation of the plasma mem-
branes are the major features of this sublytic injury. We have
described the in vitro correlates of these morphologic alter-
ations of GECs [42] and shown them to be associated with
changes in levels of intracellular messengers. In cultured rat
GECs, antibody-directed formation of C5b-9 results in Ca2
influx and mobilization of Ca2 from intracellular stores as a
consequence of phospholipase C (PLC) activation and inositol
triphosphate (1P3) production [2]. Furthermore, free AA is
released by PLA2, and TxB2 and PGFSa are generated and feed
back to further enhance PLC activity [2]. These events may
lead to altered GEC function and contribute to impaired gb-
merular permselectivity in PHN, however, our recent work
suggests that they contribute to the survival of sublethally
injured GECs as well [43]. Thus, incorporation of omega-3 fatty
acids into GEC plasma membrane phospholipids might alter
these cell signaling mechanisms and facilitate more efficient
C5b-9 shedding from the cell surface, thereby providing en-
hanced protection to the injured GEC. Alternatively, altered
membrane fluidity [44, 45], impaired CSb-9 insertion into the
plasma membrane, or improved ability of GEC to repair C5b-
9-induced injury may provide additional mechanisms by which
omega-3 incorporation exerts its favorable effect on the im-
paired gbomerular filtration barrier.
An added benefit of fish oil in this study was its ability to
lower plasma lipids. Whether this effect was due to a direct
action on hepatic lipoprotein synthesis or an indirect conse-
quence of reduced proteinuria cannot be determined from this
work. Nevertheless, this outcome could have long range advan-
tages in terms of both atherogenesis and progressive, nonim-
mune glomerular injury. Although it has not been established
that the hyperlipidemia that accompanies nephrotic syndrome
in patients and experimental animals with membranous ne-
phropathy is detrimental to the kidney, hyperlipidemia has been
shown to contribute to the development of gbomeruboscierosis
in several experimental models [46—48], in part by causing
glomerular hypertension [48]. Since elevated glomerular capil-
lary pressure is instrumental in modulating the magnitude of
proteinuria in PHN [24] and is a major factor in the pathogen-
esis of glomerubosclerosis in other disease models, there is good
reason to believe that lowering plasma lipids in PHN may be
favorable.
In summary, it appears likely that the beneficial preventive
and therapeutic effects of dietary omega-3 supplementation on
proteinuria in PHN are the result of a complex interplay
between altered inflammatory, hemodynamic and metabolic
factors. Whatever the mechanism, dietary omega-3 supplemen-
tation may offer a safe therapeutic strategy to diminish protein-
uria in patients with membranous nephropathy who have severe
and intractable edema. Additional studies are necessary, how-
ever, to assess the long-term efficacy and safety of omega-3
fatty acids on renal function and hyperlipidemia in nephrotic
subjects, and to determine if this dietary manipulation is able to
ameliorate or delay the progressive nature of this disease and its
consequences in humans.
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